Drug
Afm28
Afm28: highest development phase Phase 1, developed by Affimed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Affimed
Trials
| Drug | Phase | Indication |
|---|---|---|
| AFM28 NCT05817058 | Phase 1 | Acute Myeloid Leukemia |
Latest
No recent events.
Follow Afm28 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.